David A. Six
David A. Six publishes mostly in Molecular Biology, Molecular Medicine and Genetics, on topics such as Antibiotic Resistance in Bacteria, Bacterial Genetics and Biotechnology and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #1,096,692 of 7,710,434 ranked researchers
- Rank in United States
- #354,936 of 1,627,098
- Works
- 61
- Citations
- 5.1k
- Citations per work
- 84.2
What does David A. Six research?
David A. Six's work is mostly in Biochemistry, Genetics and Molecular Biology (55%), Medicine (6%), Agricultural and Biological Sciences (4%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences3658.9%
- Everything else2235.3%
- Health Sciences45.8%
- Medicine45.8%
- 1Molecular Biology21% of their works
- 2Molecular Medicine17% of their works
- 3Genetics13% of their works
- 4Pharmacology6% of their works
- 5Endocrinology5% of their works
- 6Plant Science4% of their works
Research topics
- Antibiotic Resistance in Bacteria
- Bacterial Genetics and Biotechnology
- Antibiotics Pharmacokinetics and Efficacy
- Escherichia coli research studies
- Bacterial biofilms and quorum sensing
- Protein Kinase Regulation and GTPase Signaling
- Pharmaceutical and Antibiotic Environmental Impacts
- Plant Pathogenic Bacteria Studies
Which keywords describe David A. Six's research?
The keywords of their largest research topics: Antibiotic Resistance, ESKAPE Pathogens, Multidrug-Resistant Bacteria, Bacterial Physiology, Gene Regulation, Virulence, Microbial Communities and Type III Secretion System.
- Plant Pathogenic Bacteria
- Resistance Genes
- Protein Kinases
- Bacteria
- Pathogenicity
- Critically Ill Patients
- Type III Secretion System
- Virulence
- Bacterial Physiology
- ESKAPE Pathogens
- Antibiotic Resistance
- Multidrug-Resistant Bacteria
- Gene Regulation
- Microbial Communities
- Antibiotic Pharmacokinetics
- Escherichia coli
- Antibiotics
- Biofilms
- Ras Signaling
- Genomics
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Antibiotic Resistance543 topics
- ESKAPE Pathogens301 topic
- Multidrug-Resistant Bacteria301 topic
- Bacterial Physiology191 topic
- Gene Regulation191 topic
- Virulence112 topics
- Microbial Communities102 topics
- Type III Secretion System102 topics
- Antibiotic Pharmacokinetics71 topic
- Critically Ill Patients71 topic
- Escherichia coli61 topic
- Pathogenicity61 topic
- Antibiotics51 topic
- Bacteria51 topic
- Biofilms51 topic
- Protein Kinases51 topic
- Ras Signaling51 topic
- Resistance Genes51 topic
- Genomics41 topic
- Plant Pathogenic Bacteria41 topic
Where does David A. Six work?
David A. Six's main affiliation in the publication record is VenatoRx Pharmaceuticals (United States), United States.
How many publications and citations does David A. Six have?
OpenAlex counts 61 works and 5,139 citations for David A. Six, an h-index of 27, ranking #1,096,692 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about David A. Six. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.